ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 283,76
0,13%
Dow Jones
42 840,26
1,18%
DAX
19 882,17
-0,17%
Brent Oil
72,525
-0,26%
Bitcoin
96 141,36
1,08%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Medimmune (MM) (MEDI) Cours

Medimmune (MM)

Medimmune (MM) (MEDI)

Harbor Health Care ETF
Myconic Capital Corp
Wellbeing Digital Sciences Inc
Myconic Capital Corp
0,00
0,00
(0,00%)
Fermé 23 Décembre 10:00PM
Retardé de 15 minutes
0,00
0,00
( 0,00% )
Avant marché: -
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
-
Prix Achat
-
Prix Vente
-
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Clôture Veille
-
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume moyen (3 m)
-
Volume financier
-
VWAP
-

MEDI Dernières nouvelles

Plus de nouvelles

MedImmune, Inc. Announces Make-Whole Fundamental Change Relating to its 1.375% Convertible Senior Notes Due 2011 and 1.625% Conv

GAITHERSBURG, Md., June 18 /PRNewswire-FirstCall/ -- MedImmune, Inc. today announced that, in connection with the closing of the acquisition of MedImmune by AstraZeneca PLC pursuant to a...

18 Juin 2007
PR Newswire (US)

MedImmune Wins Stevie(R) Award at 5th Annual American Business Awards(SM)

Biotechnology Company Honored for Internal Launch of Productivity Tracking System GAITHERSBURG, Md., June 12 /PRNewswire-FirstCall/ -- MedImmune, Inc. today announced that the company was...

12 Juin 2007
PR Newswire (US)

MedImmune Receives Correspondence From FDA Regarding FluMist(R)

GAITHERSBURG, Md., May 25 /PRNewswire-FirstCall/ -- MedImmune, Inc. (NASDAQ:MEDI) announced today that the U.S. Food and Drug Administration (FDA) has stated the agency has completed its review...

26 Mai 2007
PR Newswire (US)

Anti-Interleukin-9 Data Presented at the American Thoracic Society Meeting

PLYMOUTH MEETING, Penn., May 24 /PRNewswire-FirstCall/ -- Genaera Corporation (NASDAQ:GENR) today reported that MedImmune, Inc. (NASDAQ:MEDI) presented data related to the Interleukin-9 (IL-9...

24 Mai 2007
PR Newswire (US)

FDA Advisory Committee Recommends Expanded Use of FluMist(R)

GAITHERSBURG, Md., May 16 /PRNewswire-FirstCall/ -- MedImmune, Inc. (NASDAQ:MEDI) today announced that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products...

16 Mai 2007
PR Newswire (US)

Data Show FluMist(R) May Reduce Seasonal Influenza Burden Among Children in School, Daycare Settings

New Economic Analyses of School and Daycare Study Outcomes Suggest Vaccinating Against Influenza May Produce Cost Savings for Community at Large TORONTO, May 8 /PRNewswire-FirstCall/...

08 Mai 2007
PR Newswire (US)

MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Di

- Numax Achieves Primary Endpoint Among High-Risk Infants Versus Current Standard of Care and Shows Reduction of Medically Attended Outpatient RSV- Related Lower Respiratory Infections - TORONTO...

08 Mai 2007
PR Newswire (US)

MedImmune Provides Fellowship Grants To Six Pediatric Respiratory Researchers

- Archana Singh, M.D., Winthrop University Hospital, Receives $35,000 Grant - TORONTO, May 7 /PRNewswire-FirstCall/ -- Underscoring its commitment to pediatric medicine, MedImmune, Inc...

07 Mai 2007
PR Newswire (US)

MedImmune Provides Fellowship Grants To Six Pediatric Respiratory Researchers

- Victoria McMeen, M.D., University of Virginia, Receives $35,000 Grant - TORONTO, May 7 /PRNewswire-FirstCall/ -- Underscoring its commitment to pediatric medicine, MedImmune, Inc...

07 Mai 2007
PR Newswire (US)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

MEDI - Frequently Asked Questions (FAQ)

What is the current Medimmune share price?
The current share price of Medimmune is US$ 0,00
What is the 1 year trading range for Medimmune share price?
Medimmune has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
RELIReliance Global Group Inc
US$ 3,58
(198,33%)
20,41M
PIKKidpik Corporation
US$ 6,23
(174,45%)
5,9M
TRAWTraws Pharma Inc
US$ 9,90
(97,21%)
1,02M
EDBLEdible Garden AG Inc
US$ 0,4146
(74,42%)
39,54M
CYNCYNGN Inc
US$ 0,7661
(63,38%)
5,53M
AILEiLearningEngines Inc
US$ 0,61
(-31,07%)
160,39k
WHLMWilhelmina International Inc
US$ 3,13
(-24,21%)
408
PBMPsyence Biomedical Ltd
US$ 2,48
(-22,01%)
91,64k
CDTConduit Pharmaceuticals Inc
US$ 0,0589
(-21,15%)
3,28M
HSDTHelius Medical Technologies Inc
US$ 0,72
(-20,88%)
379,4k
EDBLEdible Garden AG Inc
US$ 0,4146
(74,42%)
39,54M
RELIReliance Global Group Inc
US$ 3,58
(198,33%)
20,41M
LAESSEALSQ Corporation
US$ 3,53
(28,36%)
12,41M
LYTLytus Technologies Holdings PTV Ltd
US$ 1,43
(36,19%)
10,54M
JDZGJIADE Ltd
US$ 0,7104
(34,01%)
10,13M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
MEDI
Medimmune
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés